A Research Guide for
ADHD & OCD

Because there is no blood test or scan for ADHD or OCD, the diagnosis rests on a careful history — and that makes an experienced evaluator worth seeking out, because the stakes of getting it right are high. The treatments for the two conditions pull in opposite directions, so a wrong label can mean a wrong (even counterproductive) treatment. A good evaluation looks at your symptoms across your whole life and in more than one setting, considers other conditions that look similar (anxiety, depression, thyroid problems, sleep disorders, trauma), and — for ADHD — confirms that the difficulties started in childhood, even if no one named them then.

Two groups are especially likely to have been missed for years. Adults: most adults diagnosed with ADHD were not identified as children, often because they were bright enough to compensate until the demands of work, parenting, or higher education outgrew their coping strategies. If you have struggled your whole life with disorganization, procrastination, restlessness, or “underachieving” relative to your ability, ADHD is worth asking about — it is not just a childhood condition. Women and girls: ADHD in females more often looks like inattention, anxiety, and low self-esteem than obvious hyperactivity, so it is frequently mistaken for an anxiety or mood problem, and many women are only diagnosed in adulthood (sometimes when their own child is diagnosed).

The practical message is to push for a thorough evaluation rather than a quick label, to bring examples and, if possible, input from someone who knew you growing up, and — if you suspect you've been missed — to say so directly. An accurate diagnosis is what makes everything that follows work.

An ADHD evaluation typically includes:

• Clinical interview: A comprehensive history of symptoms, their onset, duration, and impact across settings (home, school/work, relationships). DSM-5-TR requires at least 6 symptoms (5 for adults 17+) of inattention and/or hyperactivity-impulsivity, present for at least 6 months, with evidence that symptoms began before age 12.
• Collateral information: Reports from parents, partners, or teachers. For adult diagnosis, childhood school records or report cards can be valuable.
• Rating scales: Standardized questionnaires help quantify symptoms. Common scales include the Conners Rating Scales, the Adult ADHD Self-Report Scale (ASRS), the Conners Adult ADHD Rating Scales (CAARS), and the Vanderbilt Assessment Scales for children.
• Neuropsychological testing: Not required for diagnosis but can be helpful in complex cases. These tests measure attention, working memory, processing speed, and executive function.
• Medical evaluation: A physical exam and sometimes blood tests to rule out thyroid disorders, sleep disorders, hearing or vision problems, and other medical conditions that can mimic ADHD.

Key DSM-5-TR criteria: symptoms must be present in two or more settings (e.g., home and school/work), must cause clinically significant impairment, and must not be better explained by another mental disorder.

An OCD evaluation focuses on identifying obsessions and compulsions and measuring their severity:

• Clinical interview: Detailed exploration of the content and pattern of obsessive thoughts, the compulsions performed in response, and the impact on daily functioning. DSM-5-TR requires that obsessions and/or compulsions be time-consuming (typically more than 1 hour per day) or cause significant distress or impairment.
• Yale-Brown Obsessive Compulsive Scale (Y-BOCS): The gold-standard severity rating scale. Scores range from 0–40, with 0–7 subclinical, 8–15 mild, 16–23 moderate, 24–31 severe, and 32–40 extreme. The Children’s version (CY-BOCS) is used for pediatric patients.
• Symptom checklist: The Y-BOCS includes a checklist of common obsession and compulsion themes to ensure nothing is missed.
• Functional assessment: Understanding how OCD affects work, school, relationships, self-care, and daily routines.

Important: Many people with OCD feel ashamed of their intrusive thoughts and do not disclose them spontaneously. A skilled evaluator will ask directly and normalize the experience.

OCD manifests in many themes. Understanding the subtypes helps people recognize symptoms they might not have associated with OCD:

• Contamination: Fear of germs, illness, or bodily fluids. Compulsions include excessive handwashing, avoidance of “contaminated” objects or places, and cleaning rituals.
• Harm: Intrusive thoughts about hurting oneself or others — often loved ones. These thoughts are deeply distressing precisely because they conflict with the person’s values. Compulsions include checking, reassurance-seeking, and avoidance of sharp objects.
• Symmetry and ordering: A need for things to be “just right,” even, or symmetrical. Compulsions include arranging, counting, and repeating actions until they feel correct.
• Religious/moral scrupulosity: Excessive fear of sinning, offending God, or being immoral. Compulsions include excessive praying, confessing, or mental reviewing of past actions.
• Relationship OCD: Obsessive doubts about one’s feelings toward a partner (“Do I really love them?”), leading to reassurance-seeking and mental checking.
• “Just right” OCD: A pervasive feeling that things are “not right” without a specific feared consequence. Actions must be repeated until a sense of completeness is achieved.
• Hoarding: Classified separately in DSM-5-TR as Hoarding Disorder, but frequently co-occurs with OCD and shares treatment approaches.

The specific content of obsessions varies widely between individuals. What unites all subtypes is the cycle: intrusive thought → anxiety → compulsion → temporary relief → return of the thought.

Several conditions can be confused with ADHD or OCD. Sorting them out is essential for proper treatment:

• ADHD vs. generalized anxiety disorder (GAD): Both cause difficulty concentrating and restlessness. In ADHD, the inattention is pervasive and predates the anxiety. In GAD, concentration problems are driven by chronic worry. The two can — and frequently do — co-occur.
• OCD vs. OCPD (Obsessive-Compulsive Personality Disorder): OCPD involves perfectionism, rigidity, and preoccupation with rules — but the person generally sees these traits as consistent with their identity. OCD involves ego-dystonic intrusions — the thoughts feel foreign and unwanted.
• OCD vs. normal worry: Everyone experiences unwanted thoughts. In OCD, the thoughts are persistent, distressing, and trigger compulsive responses. The key distinction is the time, distress, and functional impairment they cause.
• ADHD vs. bipolar disorder: Both can involve impulsivity, distractibility, and talkativeness. Bipolar disorder is episodic (distinct manic and depressive periods), while ADHD is chronic and persistent. They can co-occur, and the distinction matters because stimulants can destabilize untreated bipolar disorder.
• ADHD vs. sleep disorders: Chronic sleep deprivation produces symptoms nearly identical to ADHD. A sleep evaluation should be part of any ADHD workup.

ADHD in women and girls is significantly underdiagnosed. The diagnostic criteria were originally developed based on research in boys, leading to systematic bias:

• Girls more often present with the inattentive type — less visible than hyperactive behavior, so parents and teachers are less likely to raise concerns.
• Girls are more likely to develop compensatory strategies (working harder, people-pleasing) that mask symptoms until the demands of higher education or careers overwhelm these strategies.
• Symptoms are often misattributed to anxiety or depression, leading to years of treatment for the wrong condition.
• Hormonal fluctuations (puberty, menstrual cycle, pregnancy, perimenopause) can significantly affect ADHD symptom severity.

The average age of ADHD diagnosis for girls is later than for boys, and many women are not diagnosed until their 30s, 40s, or later. Late diagnosis often brings both relief (“so that’s what was going on”) and grief for years of unnecessary struggle.

• You spend more than an hour a day on rituals or fighting unwanted thoughts
• The thoughts feel “stuck” — you cannot dismiss them the way you can dismiss other worries
• You avoid specific places, people, or situations because they trigger the thoughts
• You seek reassurance repeatedly (“Are you sure I didn’t hurt anyone?”) and feel better only briefly
• You feel compelled to repeat actions a specific number of times or until they feel “right”
• You recognize the thoughts are irrational but cannot stop responding to them
• The content of the thoughts is deeply disturbing to you — often the opposite of what you value

If several of these apply, discuss them with a mental health professional experienced in OCD. You do not need to disclose the specific content of the thoughts to start the conversation — you can simply say “I’m having intrusive thoughts that I can’t control.”

These are not diagnostic instruments on their own, but they can help initiate a conversation with your provider:

• Adult ADHD Self-Report Scale (ASRS-v1.1): A 6-question screener developed by the WHO. Available free online. A positive screen (4+ items) indicates further evaluation is warranted.
• Conners Adult ADHD Rating Scales (CAARS): A more comprehensive self-report and observer-report instrument used in clinical evaluations.
• Vanderbilt Assessment Scales: Widely used for children ages 6–12, completed by parents and teachers.
• Weiss Functional Impairment Rating Scale (WFIRS): Measures functional impairment across domains (family, work, school, social).

Bring completed screening questionnaires to your appointment. They give the clinician a starting point and save time.

Many adults pursue an ADHD or OCD diagnosis after years of unexplained struggles. The process can feel daunting, but it follows a clear path:

1. Start with your primary care provider. They can perform initial screening, rule out medical causes, and refer to a specialist.
2. Find a qualified evaluator. Psychiatrists, clinical psychologists, and neuropsychologists can all conduct ADHD evaluations. For OCD, look for providers who specifically list OCD and ERP in their specialties.
3. Gather documentation. School records, old report cards (comments like “doesn’t apply herself” or “very bright but disorganized” can be revealing), and observations from partners or family members.
4. Be honest and thorough. Describe your symptoms across settings and over time. Mention compensatory strategies you use — clinicians who understand adult ADHD know that “getting by” does not mean “no disorder.”
5. Expect the process to take time. A thorough evaluation may span 2–4 sessions. Avoid providers who diagnose in a 15-minute visit without a comprehensive history.

Insurance coverage for neuropsychological testing varies. Ask about costs upfront and whether your plan covers evaluation.

• What specific evaluation process will you use to diagnose ADHD or OCD?
• How many adults with ADHD/OCD do you evaluate per year?
• Should I have neuropsychological testing? What would it add?
• Could my symptoms be caused by a sleep disorder, thyroid condition, or another medical issue?
• If you diagnose ADHD or OCD, what are the next steps for treatment?
• Do you also screen for conditions that commonly co-occur, such as anxiety, depression, or learning disabilities?
• How long will the evaluation take, and what should I bring to the appointment?
• For OCD: Do you use the Y-BOCS or CY-BOCS to measure severity?

ADHD medications are, by the numbers, among the most effective treatments in all of mental health — most people who take them experience clear improvement in focus, follow-through, and impulse control. There are two broad types: stimulants (methylphenidate- and amphetamine-based), which work within an hour and are first-line for most people, and non-stimulants (atomoxetine, viloxazine, guanfacine, clonidine), which build up over weeks and are good options when stimulants aren't tolerated, aren't safe, or aren't preferred. Finding the right medication and dose is usually a process of adjustment — if the first doesn't work well, a different one often will, so an imperfect start is normal, not failure.

A few persistent myths deserve correcting. “Stimulants are just legal speed and will lead to addiction.” At prescribed doses for ADHD, the opposite is true: treating ADHD actually lowers the long-term risk of substance problems, because untreated ADHD is itself a major risk factor. “They'll change my (or my child's) personality.” Well-dosed medication should make you more yourself — more able to do what you intend — not flat or zombie-like; if it doesn't, the dose or drug needs adjusting. “It's a crutch.” ADHD reflects real differences in brain chemistry; using medication for it is no more a crutch than glasses are for vision.

Practical expectations: side effects like reduced appetite or trouble sleeping are common early and usually manageable (with timing, food, or dose changes), your clinician will track height, weight, blood pressure, and heart rate, and medication works best alongside structure and skills — not instead of them. If something feels off, the answer is to adjust with your prescriber, not to quietly stop.

If you have struggled to fill an ADHD stimulant prescription, you are not alone — an ongoing national shortage has made this a widespread and stressful problem. A few strategies help. Don't run out silently: tell your prescriber early if you're having trouble, because they can often help. Ask about options: a different but equivalent formulation, a different pharmacy (independent and grocery-store pharmacies sometimes have stock when big chains don't), or a 90-day supply when your insurance and the law allow. Calling pharmacies to check stock before the prescription is sent can save days of back-and-forth.

A second, important option is the non-stimulant medications, which are not affected by the stimulant shortage and are genuinely effective. Atomoxetine and viloxazine (Qelbree) provide all-day coverage without being controlled substances, and the alpha-2 agonists (guanfacine, clonidine, including the newer liquid form) help with impulsivity and sleep. They take a few weeks to work rather than acting immediately, but for someone facing repeated shortages they can be a more reliable foundation — ask whether one is right for you.

Most importantly: do not abruptly stop a stimulant you have been taking long-term if you hit a gap — talk to your prescriber about bridging it (with a non-stimulant or an alternative formulation) rather than going without. Shortages are frustrating and not your fault, but with some planning and flexibility from your care team, almost everyone can stay treated through them.

Stimulant medications are the first-line pharmacological treatment for ADHD in both children and adults. They work by increasing dopamine and norepinephrine availability in the prefrontal cortex, improving executive function.

Methylphenidate-based medications:

• Short-acting: Ritalin, Methylin (immediate release, duration 3–4 hours, typically dosed 2–3 times daily)
• Intermediate-acting: Ritalin LA, Metadate CD (duration 6–8 hours)
• Long-acting: Concerta (OROS delivery system, duration 10–12 hours), Jornay PM (evening-dosed for next-morning coverage), Daytrana (transdermal patch), Focalin XR (dexmethylphenidate)
• Azstarys (serdexmethylphenidate, a prodrug, plus immediate-release dexmethylphenidate) — FDA approved March 2021 for ages 6 and older; once-daily capsule.

Amphetamine-based medications:

• Short-acting: Adderall (mixed amphetamine salts, immediate release, duration 4–6 hours)
• Long-acting: Adderall XR (duration 10–12 hours), Vyvanse (lisdexamfetamine, prodrug with smoother onset/offset, duration 12–14 hours, lower abuse potential due to prodrug formulation)

There is no way to predict which stimulant class will work best for a given individual. If the first medication tried is ineffective or causes problematic side effects, switching to the other class is the standard next step. Approximately 70–80% of people respond to one or both classes.

Non-stimulants are used when stimulants are ineffective, cause intolerable side effects, are contraindicated, or when the patient prefers to avoid stimulants:

• Atomoxetine (Strattera): A selective norepinephrine reuptake inhibitor. Takes 4–6 weeks for full effect. No abuse potential. Particularly useful for people with co-occurring anxiety or substance use concerns.
• Guanfacine ER (Intuniv): An alpha-2A adrenergic agonist. FDA approved for children 6–17. Helps with hyperactivity, impulsivity, and emotional dysregulation. Can cause sedation and low blood pressure.
• Clonidine ER (Kapvay): Another alpha-2 agonist, similar mechanism to guanfacine. FDA approved for children 6–17. More sedating than guanfacine.
• Viloxazine ER (Qelbree): A norepinephrine reuptake inhibitor with additional serotonin (5-HT2C/5-HT2B) activity. FDA approved for children and adolescents ages 6–17 (2021) and adults (2022). A newer option with a different mechanism from stimulants. Not a controlled substance. Carries a warning for suicidal thoughts/behavior.
• Onyda XR (clonidine ER oral suspension): FDA approved May 2024 — the first and only liquid (non-tablet) non-stimulant for ADHD, for ages 6 and older. An extended-release alpha-2 agonist taken at night, used alone or added to a stimulant. Helpful for children who cannot swallow pills.

Non-stimulants generally have smaller effect sizes than stimulants (d = 0.3–0.5) but are valuable alternatives and can be combined with stimulants for additional benefit.

Common stimulant side effects and management:

• Decreased appetite: The most common side effect. Take medication with or after meals. Monitor weight, especially in children. Growth should be tracked at every visit.
• Sleep difficulties: Stimulants can delay sleep onset. Strategies include taking medication earlier in the day, using shorter-acting formulations, practicing sleep hygiene, and in some cases adding melatonin.
• Cardiovascular effects: Mild increases in heart rate (3–6 bpm) and blood pressure (2–4 mmHg) are common. Baseline and periodic monitoring of heart rate and blood pressure is standard. Cardiac screening (ECG) is recommended only if there is a personal or family history of cardiac problems.
• Tics: Stimulants can sometimes cause or worsen motor or vocal tics. If tics develop, reducing the dose, switching medication, or adding an alpha-2 agonist may help.
• Mood effects: Some people experience irritability, emotional flatness, or a “rebound” effect as medication wears off. Dose adjustment or switching formulations typically resolves this.
• Growth concerns in children: Long-acting stimulants may slightly slow growth velocity in the first 1–2 years, but most evidence suggests final adult height is not significantly affected.

Since 2022, the United States has experienced an ongoing shortage of stimulant medications — particularly amphetamine-based formulations. A CDC MMWR 2024 report found that 71.5% of adults taking stimulant medication for ADHD reported difficulty filling their prescription. Contributing factors include increased demand following pandemic-era awareness, DEA production quotas, and manufacturing delays.

Strategies for managing the shortage:

• Ask your pharmacist to check availability across multiple locations and manufacturers
• Work with your prescriber to identify alternative formulations or medications
• Plan ahead — contact the pharmacy at least one week before running out
• Consider mail-order pharmacies, which may have different inventory
• Do not stop medication abruptly without consulting your prescriber

Medication addresses the neurochemistry; behavioral strategies address the skills gap. Both are important:

• Organizational systems: External structure compensates for internal executive function difficulties. Use planners (paper or digital), to-do lists, calendar blocking, and visual reminders. The best system is one you will actually use — perfection is the enemy of function.
• Time management: Time blindness is a core ADHD feature. Use timers (visual timers are especially effective for children), alarms, and time-blocking. The Pomodoro technique (25 minutes of work, 5 minutes of break) works well for many.
• Environment modification: Reduce distractions: noise-canceling headphones, clean workspace, website blockers, phone in another room during focused work. Set up your environment so that the desired behavior is the easiest one.
• Exercise: Robust evidence supports regular aerobic exercise as an adjunct treatment for ADHD. A meta-analysis found moderate effect sizes (d = 0.5) for attention improvement with exercise. Even 20–30 minutes of moderate activity can improve focus for hours afterward.
• Body doubling: Working alongside another person — even silently — can help sustain focus. Virtual body-doubling communities exist online.

ADHD coaching is a specialized form of coaching (distinct from therapy) that helps people develop systems for managing executive function challenges. A coach works with you on practical skills:

• Planning and prioritizing tasks
• Breaking large projects into manageable steps
• Building and maintaining routines
• Accountability and follow-through
• Managing transitions and deadlines
• Emotional regulation strategies

Coaching is not a substitute for therapy or medication but can be a valuable complement. Look for coaches certified through organizations like the Professional Association of ADHD Coaches (PAAC) or the ADHD Coaches Organization (ACO). Some coaches offer sessions specifically for college students, professionals, or parents.

Technology-based interventions are emerging as adjuncts to traditional ADHD treatment:

• EndeavorRx (AKL-T01): The first FDA-cleared digital therapeutic for ADHD, approved for children ages 8–12 with the primarily inattentive or combined presentation. It is a video-game-like program designed to target attention function through sensory stimuli and simultaneous motor challenges. Prescribed by a physician. Clinical trials showed improvements in attention measures, though effect sizes are modest.
• ADHD management apps: Apps like Tiimo, Focusmate, and Forest can support time management and focus, though they are not FDA-regulated treatments.
• Neurofeedback: Brain-computer interface training that aims to teach self-regulation of brain activity. Evidence is mixed — some studies show modest benefits, but the most rigorous trials have not demonstrated effects superior to sham training. Not yet recommended as a primary treatment by major guidelines.

If you are a parent, partner, or family member of someone with ADHD:

• Understand that ADHD behaviors are not intentional. Forgetfulness, lateness, and disorganization are symptoms, not character flaws. Responding with frustration or criticism worsens self-esteem without improving behavior.
• Help build external structure. Routines, checklists, and reminders in shared spaces (not nagging) support the person without creating conflict.
• Monitor medication in children. Track timing, dosing, appetite, sleep, and mood. Keep a log to share with the prescriber. Children cannot reliably self-manage medication.
• Model and reinforce organizational strategies. Children learn executive function skills through scaffolding — doing it with them, then fading support as they become more independent.
• Take care of your own mental health. Parenting a child with ADHD or partnering with an adult with ADHD is demanding. Support groups, therapy, and respite are not luxuries — they are essential.

• Do you recommend starting with a stimulant or non-stimulant medication, and why?
• Which specific medication and formulation do you suggest, and how long until it takes full effect?
• What side effects should I watch for, and when should I call?
• How will we monitor for cardiovascular effects? Is a baseline ECG needed?
• For children: how will we track growth, and should we consider medication holidays?
• If the first medication doesn’t work, what is the plan?
• Do you recommend behavioral therapy or coaching in addition to medication?
• I also have OCD (or anxiety). Does that change the medication choice?
• Are there generic versions available, and with the stimulant shortage, do you have a backup plan?

The most effective treatment for OCD is a specific kind of therapy called Exposure and Response Prevention (ERP), and understanding why it works — and why it feels counterintuitive — helps you commit to it. OCD runs on a vicious cycle: an intrusive thought creates intense anxiety, you perform a compulsion (washing, checking, mental reviewing, seeking reassurance) to relieve it, the relief is real but temporary, and the cycle teaches your brain that the compulsion was “necessary” — so the anxiety comes back stronger. ERP breaks the cycle by having you deliberately face the trigger (exposure) without doing the compulsion (response prevention). The anxiety rises — and then, crucially, falls on its own, teaching your brain that you can tolerate it and that the feared catastrophe doesn't happen.

This is hard, and it should be done with a trained ERP therapist who helps you build a step-by-step ladder from easier to harder exposures at a pace you can manage — not thrown into the deep end. Done well, it works: most people see substantial improvement, and the gains tend to last because you have actually rewired the response. Intensive formats (even concentrated 4-day programs) exist for those who need them or can't access weekly therapy.

Two practical notes. First, ERP is a specific skill — ordinary “talk therapy” or generic counseling is not the same thing and is much less effective for OCD, so it is worth specifically asking a therapist whether they are trained in ERP. Second, medication (SSRIs) makes ERP easier for many people and is often combined with it, especially for moderate-to-severe OCD. The combination of ERP plus medication is the most powerful approach.

One of the most important and least intuitive facts about OCD is that the natural ways we try to soothe anxiety — for ourselves or for someone we love — often feed the disorder instead of calming it. Reassurance is the clearest example: when a person with OCD asks “are you sure I locked the door?” or “do you think I'm a bad person for having that thought?”, answering — however lovingly — provides the same temporary relief a compulsion does, and so trains the brain to seek it again. This is why family members are often coached to lovingly reduce reassurance (a process therapists guide carefully), and why endlessly researching or “figuring out” an obsession is itself a compulsion that keeps OCD alive.

For the same reason, telling someone with OCD to “just stop worrying” or “just don't do the ritual” doesn't work and adds shame — the whole problem is that the urge feels unbearable to resist without the right tools. And approaches that only reduce anxiety in general (relaxation alone, or anti-anxiety sedatives like benzodiazepines) can actually undermine recovery, because OCD is beaten by learning to tolerate the anxiety, not by avoiding or numbing it.

What does help is the structured ERP approach — facing the fear and resisting the compulsion with support — plus, often, medication. If you are a family member, the most useful things you can do are: learn about the disorder, gently reduce accommodation and reassurance (ideally with the therapist's guidance), support the person's ERP work, and treat the intrusive thoughts as symptoms rather than as reflections of who they are. Understanding this reframes a frustrating dynamic into something you can actually act on.

ERP is the gold-standard psychotherapy for OCD, with 60–80% of patients showing significant improvement. Here is how it works:

1. Build a fear hierarchy: You and your therapist create a ranked list of OCD triggers, from least to most distressing (rated on a Subjective Units of Distress Scale, 0–100).
2. Gradual exposure: Starting with less distressing items, you deliberately confront the trigger — the intrusive thought, the contaminated surface, the “incomplete” arrangement. Exposures can be in vivo (real-life), imaginal (visualized), or interoceptive (body sensations).
3. Response prevention: During and after the exposure, you resist performing the compulsion. No washing, no checking, no reassurance-seeking, no mental rituals.
4. Habituation and learning: Over time, the anxiety naturally decreases. Your brain learns that the feared outcome does not occur and that anxiety is tolerable. This is called inhibitory learning — the new, safe association gradually becomes stronger than the old, fearful one.

A typical course of ERP is 12–20 sessions, though this varies with severity. Between-session homework (self-directed exposures) is critical to progress. Treatment is uncomfortable by design — temporary discomfort is the pathway to lasting relief.

Developed in Bergen, Norway, this intensive ERP format concentrates treatment into four consecutive days with individual therapist guidance. It has shown remarkable results:

• 73% remission rate (Y-BOCS score ≤ 12) at post-treatment
• 69% recovery rate maintained at 4-year follow-up
• Delivered in a group format with individual therapist guidance during exposures

The intensive format may be particularly suited to people who benefit from full immersion rather than weekly sessions. A growing number of OCD specialty centers offer intensive treatment formats modeled on this approach, including 3–5 day intensives and residential programs.

Selective Serotonin Reuptake Inhibitors (SSRIs) are the first-line medications for OCD. A critical point that many patients and even some providers miss: OCD requires higher SSRI doses than depression.

• Fluoxetine (Prozac): 40–80 mg/day for OCD (vs. 20 mg for depression)
• Fluvoxamine (Luvox): 200–300 mg/day — FDA-approved for OCD. (Several SSRIs carry FDA OCD indications: fluoxetine, fluvoxamine, sertraline, and paroxetine; escitalopram is used off-label.)
• Sertraline (Zoloft): 150–200 mg/day for OCD (vs. 50–100 mg for depression)
• Paroxetine (Paxil): 40–60 mg/day for OCD
• Escitalopram (Lexapro): 20–40 mg/day for OCD (higher than the typical 10–20 mg for depression; off-label for OCD but commonly used)

Timeline: SSRIs for OCD take longer to work than for depression. Allow 8–12 weeks at an adequate dose before concluding that a medication is ineffective. This is twice as long as the typical antidepressant trial. Many patients are switched prematurely because providers apply depression timelines to OCD.

Response rates: Approximately 40–60% of OCD patients respond to an SSRI. Response is defined as a 25–35% reduction in Y-BOCS score. Full remission on medication alone is less common — which is why combined treatment (ERP + SSRI) is superior to either alone for moderate-to-severe OCD.

Clomipramine (Anafranil): A tricyclic antidepressant and the oldest effective medication for OCD. It is the most serotonergic of the tricyclics and may be the most effective single medication for OCD. However, its side effect profile (weight gain, sedation, dry mouth, constipation, cardiac effects) limits its use as a first-line agent. It is typically tried when SSRIs have been inadequate.

Augmentation for partial responders: When an adequate SSRI trial produces partial but insufficient response, the following strategies have evidence:

• Low-dose atypical antipsychotics: Aripiprazole (2–10 mg) or risperidone (0.5–2 mg) added to the SSRI. Meta-analyses show a 30–50% improvement in SSRI partial responders. Aripiprazole has a more favorable metabolic profile.
• Adding ERP: If the patient has not yet received ERP, adding it to an SSRI is the most impactful augmentation strategy.
• Switching SSRIs: If one SSRI is ineffective, trying a different one is reasonable — some patients respond to one but not another.

Treatment-resistant OCD: For severe, treatment-resistant OCD (failed adequate trials of multiple SSRIs, clomipramine, and ERP), specialized approaches include glutamate modulators, deep brain stimulation (FDA-approved under a Humanitarian Device Exemption), and intensive residential treatment programs.

Finding a therapist specifically trained in ERP is the most critical step. Many therapists say they treat OCD but do not use ERP. Here is how to find the right one:

• IOCDF Therapist Directory: The International OCD Foundation (iocdf.org) maintains a searchable directory of OCD specialists. This is the best starting point.
• Questions to ask a potential therapist:
  • “What percentage of your caseload has OCD?” (Aim for a therapist where OCD is a significant part of their practice.)
  • “Do you use Exposure and Response Prevention?” (The answer should be an unequivocal yes.)
  • “Will I be doing exposures in session?” (Yes — exposures are done during sessions, not just discussed.)
  • “What training have you received in ERP?” (Look for specific training programs, workshops, or supervision.)
• Teletherapy: ERP can be delivered effectively via telehealth. This greatly expands access for people in areas without local OCD specialists. NOCD and other platforms offer ERP-trained therapists via video.

Family accommodation occurs when family members participate in or facilitate the person’s OCD rituals — often with the best of intentions. Examples include:

• Providing excessive reassurance (“No, you didn’t leave the stove on”)
• Helping with rituals (washing items for the person, checking locks for them)
• Modifying the household routine to avoid triggers
• Answering the same questions repeatedly

Why it matters: Research consistently shows that higher family accommodation is associated with more severe OCD and poorer treatment outcomes. Accommodation provides short-term relief but reinforces the OCD cycle long-term.

What to do instead:

• Work with the therapist to develop a plan for gradually reducing accommodation
• Express empathy for the distress without participating in the ritual: “I can see this is really hard for you, and I love you, but the therapist asked us not to check again.”
• Consider SPACE (Supportive Parenting for Anxious Childhood Emotions) — an evidence-based parent training program specifically designed for reducing family accommodation
• Attend family therapy sessions when offered

• Do you recommend starting with ERP, medication, or both?
• If medication, which SSRI do you recommend, and at what dose? Is this an OCD-specific dose?
• How long should I take the medication before we know if it’s working?
• Can you refer me to a therapist who specifically uses ERP?
• If I’ve tried ERP and SSRIs without adequate improvement, what are the next steps?
• Should I consider an intensive program (residential or outpatient intensive)?
• How long should I remain on medication once OCD is well controlled?
• Are there risks to combining an SSRI with other medications I’m taking?
• My family member accommodates my OCD — how do we address that as part of treatment?

Having both ADHD and OCD — which is more common than chance — can feel contradictory: ADHD pulls you toward distraction and acting on impulse, while OCD pulls you toward rigid rituals and over-control. They genuinely complicate each other, and the single most useful thing to understand is that the order in which they are treated matters. In general, if the OCD is moderate or severe, clinicians stabilize it first (with ERP therapy and an SSRI) before fully tackling the ADHD — because untreated OCD makes it very hard to benefit from ADHD treatment, and because ADHD stimulants can occasionally stir up obsessive symptoms in some people. Once the OCD is more settled, ADHD treatment is added carefully, watching to make sure the obsessions don't flare.

This is not a rigid rule — if ADHD is clearly the bigger problem and the OCD is mild, the order can flip — but it explains why your care team may seem to focus on one condition before the other rather than treating everything at once. When ADHD treatment is added to fragile OCD, a non-stimulant is sometimes chosen first, or a stimulant is started low and increased slowly with check-ins.

A subtle point that often causes confusion: some repetitive behaviors (like impulsively picking at skin, or checking things over and over) can come from either condition, and they are treated differently depending on the source — OCD compulsions (driven by anxiety and a dreaded “what if”) respond to ERP, while ADHD-driven habits respond to habit-reversal techniques and stimulant treatment. Sorting out which is which is part of why a careful evaluation, and a clinician comfortable with both conditions, is so valuable when you have both.

It is common for ADHD and OCD to come with other conditions, and knowing the usual companions helps you make sense of the whole picture rather than feeling like you have a confusing pile of unrelated problems. Tics and Tourette syndrome frequently travel with both ADHD and OCD — brief, involuntary movements or sounds that wax and wane. Reassuringly, the old worry that ADHD stimulants always worsen tics has not held up; stimulants can usually be used safely, and when tics are prominent, certain ADHD medications (the alpha-2 agonists guanfacine and clonidine) help both at once. Anxiety and depression are also common companions and are very treatable; sometimes treating them is what finally lets the ADHD or OCD treatment work.

For people with ADHD, learning differences (like dyslexia) often coexist and are worth testing for, because medication helps attention but doesn't fix a specific learning disability — that needs educational support. And both conditions can come with emotional ups and downs and difficulty with self-esteem after years of struggle, which therapy and the right treatment can substantially improve.

The takeaway is not that you should worry about collecting diagnoses, but that a thorough evaluation looks at the whole person rather than a single label — because treating the companions (the sleep problem, the anxiety, the learning difference) is often what unlocks progress on the main condition. If something doesn't fit the ADHD or OCD picture, it is worth raising; the goal is a plan that addresses everything that is actually getting in your way.

The overlap between ADHD and OCD is well documented:

• 10–25% of people with OCD also meet criteria for ADHD
• 10–20% of people with ADHD have clinically significant OCD symptoms
• Both rates are substantially higher than would be expected by chance, suggesting shared neurobiological vulnerability
• The co-occurrence is more common in males and in those with childhood-onset OCD

When both conditions are present, the overall impairment tends to be greater than with either condition alone. People with comorbid ADHD and OCD report more difficulty with daily functioning, relationships, and quality of life.

The standard approach for comorbid ADHD and OCD is to address OCD first, typically with ERP and an SSRI, for several reasons:

• Stimulants and OCD: Although the evidence is mixed, stimulant medications can theoretically worsen OCD symptoms in some individuals by increasing dopaminergic activity in circuits that overlap with OCD pathways. Starting stimulants before OCD is stabilized risks destabilizing OCD.
• OCD impairs attention independently: Intrusive thoughts consume cognitive resources. What looks like ADHD inattention may partly resolve once OCD is treated. It is difficult to assess true ADHD severity while OCD is active.
• ERP requires sustained attention: Engaging in ERP requires the ability to focus and tolerate discomfort. Severe untreated ADHD can undermine this. Some clinicians therefore titrate a low dose of stimulant first to enable ERP participation — this is a clinical judgment call.

A practical sequence:

1. Begin an SSRI at an OCD-appropriate dose. Allow 8–12 weeks.
2. Start ERP therapy concurrently or once the SSRI has taken initial effect.
3. Once OCD is stabilized (typically 3–6 months), reassess ADHD symptoms.
4. If significant ADHD symptoms persist, introduce stimulant medication cautiously at a low dose with close monitoring of OCD symptoms.

ADHD and OCD share some neuroanatomy but differ in fundamental ways:

• Shared circuits: Both involve the frontostriatal circuitry — connections between the prefrontal cortex and the basal ganglia. However, different sub-loops within this system are implicated in each disorder.
• ADHD neurobiology: Primarily involves dopamine and norepinephrine deficits in the dorsolateral prefrontal cortex and dorsal striatum — circuits responsible for executive function, working memory, and response inhibition.
• OCD neurobiology: Primarily involves serotonin and glutamate dysregulation in the orbitofrontal cortex, anterior cingulate cortex, and ventral striatum — circuits involved in error detection, threat assessment, and habit formation.
• Where they intersect: The anterior cingulate cortex plays a role in both conditions — in ADHD as a node for attention allocation, and in OCD as part of the error-detection system. This shared anatomy may partly explain the clinical overlap.

Tic disorders — including Tourette syndrome — frequently co-occur with both ADHD and OCD, forming a triad that shares genetic and neurobiological roots:

• 60–80% of people with Tourette syndrome also have ADHD
• 20–60% of people with Tourette syndrome also have OCD
• OCD that co-occurs with tics tends to feature more “just right” and symmetry obsessions, compared to the harm and contamination themes more common in non-tic-related OCD

The presence of tic disorders affects medication choices. Alpha-2 agonists (guanfacine, clonidine) can address both tics and ADHD. When OCD co-occurs with tics, augmentation of an SSRI with a low-dose antipsychotic (such as aripiprazole) may target both the OCD and the tics.

Both ADHD and OCD are frequently accompanied by additional conditions. Recognizing these is important for comprehensive treatment:

• Anxiety disorders: Generalized anxiety, social anxiety, and panic disorder co-occur with both ADHD (25–50%) and OCD (75%).
• Depression: Major depression affects 30–50% of adults with ADHD and up to 67% of people with OCD over their lifetime. It is often secondary — driven by the chronic burden of the primary condition.
• Learning disabilities: Dyslexia, dyscalculia, and other learning disorders co-occur with ADHD in 20–40% of cases. Neuropsychological testing can identify these.
• Substance use disorders: Adults with untreated ADHD have a 2–3 times higher risk of substance use disorders. Treatment of ADHD reduces this risk. OCD can also drive substance use as a maladaptive coping mechanism.
• Eating disorders: OCD and eating disorders share features of rigidity and ritualistic behavior. ADHD is associated with binge eating disorder.
• Autism spectrum disorder: Repetitive behaviors in autism can resemble OCD compulsions. Co-occurrence with ADHD is common. Distinguishing these conditions requires careful evaluation.

• I have both ADHD and OCD. Which condition should we treat first, and why?
• Is it safe for me to take a stimulant and an SSRI together?
• If we start ADHD medication, how will you monitor for worsening OCD?
• I also have tics — does that change the medication plan?
• Are there specialists who treat co-occurring ADHD and OCD together?
• How will we know which symptoms are from ADHD and which are from OCD?
• Should I be screened for other conditions that commonly co-occur?
• Is there a therapy approach that addresses both conditions simultaneously?

Because both ADHD and OCD often affect people during their reproductive years, pregnancy, postpartum, and hormonal changes deserve specific attention — and the guidance is reassuring but nuanced. For OCD in pregnancy, the key message echoes the rest of medicine: untreated moderate-to-severe OCD carries real costs, and ERP therapy is safe and first-line, while SSRIs (sertraline is often preferred) are generally continued when needed, with paroxetine usually avoided. A particularly important and under-recognized issue is postpartum OCD: many new parents experience sudden, horrifying intrusive thoughts about harm coming to the baby. These are deeply distressing precisely because the parent would never act on them — and that is the crucial distinction from rare postpartum psychosis. Postpartum OCD is common, treatable, and not a sign you are dangerous; tell your clinician, because the relief of naming it and getting ERP-based help is enormous.

For ADHD in pregnancy, stimulants are often paused because safety data are limited, so non-medication strategies and structure carry more of the load during this period; decisions about restarting (and about medication while breastfeeding) are individual risk-benefit conversations with your clinician rather than one-size-fits-all rules. Many women also notice their ADHD symptoms shift with the menstrual cycle and around menopause, because estrogen affects the brain chemicals ADHD medication targets — if you notice predictable monthly or midlife worsening, it is worth raising, as adjustments can help.

The broader point across the lifespan is that the same condition needs different handling at different stages — behavioral approaches first in young children, attention to autonomy and adherence in teens, and awareness of hormones, pregnancy, and other medications in adults — so treatment should be revisited at life transitions rather than set once and forgotten.

If your child has just been diagnosed with ADHD or OCD, a few orienting points help you start well. First, a diagnosis is good news in disguise: it names something real, opens the door to effective treatment, and replaces blame (“he's lazy,” “she's just difficult”) with understanding. Children do far better when the adults around them — parents and teachers — understand that the behaviors are symptoms, not defiance or attention-seeking.

For childhood ADHD, treatment is usually a combination of behavioral approaches and, for school-age children, medication; for the youngest children (preschoolers), behavioral parent training comes first. School support matters enormously — a 504 plan or IEP can provide accommodations like extra time, movement breaks, and seating changes — and the evidence is reassuring that treating ADHD helps academic, social, and safety outcomes (including lowering the later risk of substance problems and accidents). For childhood OCD, ERP adapted for children, often involving the family, is first-line; SSRIs are added for moderate-to-severe cases.

Two parenting reframes help most. Reduce accommodation of OCD (gently, with the therapist's guidance) rather than helping with rituals, and respond to ADHD behaviors with structure, clear expectations, and praise for effort rather than punishment. Look after yourself and the family system too — parenting a child with these conditions is demanding, and organizations like CHADD and the IOCDF offer parent programs and community. With early, evidence-based help, most children with ADHD or OCD grow into capable, thriving adults; the diagnosis is the beginning of getting them the right support, not a limit on their future.

Treatment guidelines from the American Academy of Pediatrics (AAP) distinguish by age:

• Preschool (ages 4–5): Behavioral interventions are first-line. Parent-delivered behavioral training (parent training in behavior management, PTBM) is the recommended starting point. Medication (methylphenidate) is considered only when behavioral interventions are insufficient and impairment is moderate-to-severe.
• School-age (ages 6–11): FDA-approved medications (stimulants or non-stimulants) combined with behavioral therapy and classroom accommodations. Medication and behavioral interventions together produce better outcomes than either alone.
• Adolescents (ages 12–17): Medication remains first-line, with increasing emphasis on the adolescent’s own involvement in treatment decisions. Behavioral skills training, organization skills training, and family therapy are important adjuncts.

Behavioral interventions for pediatric ADHD include parent training, teacher consultation, organizational skills training, and social skills groups. Evidence-based parent training programs include the Incredible Years, Triple P, and Parent-Child Interaction Therapy (PCIT).

OCD in children and adolescents responds to the same core treatments as in adults, with important adaptations:

• Mild-to-moderate OCD: CBT with ERP is first-line. The therapist adapts exposures to be age-appropriate and engages the child in designing the exposure hierarchy. Younger children benefit from gamifying the process and externalizing OCD (naming it as a “bully” or “annoying character”).
• Moderate-to-severe OCD: Combined CBT + SSRI. Fluoxetine and fluvoxamine have the strongest evidence base for pediatric OCD. Sertraline is also FDA-approved for children.
• Parent involvement: Parents are active participants in pediatric OCD treatment. They learn about OCD, practice reducing accommodation, and support between-session exposures.
• SPACE program: For children who refuse or cannot engage in ERP, the SPACE (Supportive Parenting for Anxious Childhood Emotions) program works exclusively through parents, reducing accommodation and changing the family’s response to OCD. Randomized trials show it is as effective as child-directed CBT.

Adolescence brings specific challenges for both conditions:

• Medication adherence: Teens often push back against taking medication. Involving them in treatment decisions, explaining the rationale, and addressing concerns about identity (“Is this still me on medication?”) improves adherence.
• Peer relationships: Both ADHD and OCD can affect friendships. Social skills training (for ADHD) and gradual exposure to social triggers (for OCD) can help.
• Identity and self-esteem: Adolescents with ADHD often internalize messages about being “lazy” or “undisciplined.” Those with OCD may feel shame about their intrusive thoughts. Therapy should explicitly address self-concept.
• Substance use risk: Adolescents with ADHD have elevated risk for substance experimentation. Treated ADHD actually reduces this risk. Open conversations about substance use are important.
• Transition planning: Before leaving for college or independent living, build self-management skills: pharmacy management, appointment scheduling, recognizing warning signs, and knowing when to seek help.
• Driving: ADHD significantly increases the risk of motor vehicle accidents, particularly in new drivers. Medication improves driving performance. This is an important safety conversation.

Adult ADHD is increasingly recognized. CDC 2024 data shows 6.0% prevalence among U.S. adults, with 55.9% first diagnosed as adults — many after years or decades of struggling without understanding why.

Workplace impacts and strategies:

• Difficulty with meetings, deadlines, email management, and sustained attention on non-preferred tasks
• Strategies: time-blocking, breaking tasks into smaller units, using project management tools, requesting accommodations (see below), working with an ADHD coach
• Many adults with ADHD thrive in roles that match their strengths: creativity, crisis management, entrepreneurship, and high-stimulation environments

Relationship impacts:

• Partners may feel burdened by the organizational and emotional labor of managing the household
• The ADHD partner may feel criticized and misunderstood
• Couples therapy with a therapist who understands ADHD can help both partners develop realistic expectations and shared systems

Late diagnosis emotional impact: Adults diagnosed later in life often experience a complex mix of relief, grief, anger, and reframing of their past. Support groups and therapy can help process these feelings.

OCD is typically a chronic condition that waxes and wanes over the lifespan. Most adults with OCD manage it as a long-term condition, not a one-time problem to solve:

• Relapse prevention: After successful ERP, periodic “booster” sessions help maintain gains. Many people learn to conduct their own exposures using the skills from therapy.
• Stress and flare-ups: OCD symptoms often intensify during major life transitions — new jobs, moves, relationship changes, parenthood. Knowing this pattern allows preemptive management.
• Postpartum OCD: A specific and often misunderstood presentation. New mothers (and sometimes fathers) experience intrusive thoughts about harming their baby. These thoughts are ego-dystonic (deeply distressing and contrary to the parent’s wishes) and are not the same as psychotic thoughts. Postpartum OCD responds well to ERP and SSRIs.
• Late-onset OCD: OCD can begin or re-emerge in middle age or later. Medical conditions, medications, and neurological changes can contribute. New-onset OCD in older adults warrants medical evaluation.

Hormonal fluctuations can significantly affect both ADHD and OCD symptoms:

• Menstrual cycle: Many women report ADHD and OCD symptom worsening in the premenstrual phase, when estrogen drops. Estrogen has a modulatory effect on both dopamine and serotonin systems. Tracking symptoms across the cycle can help identify patterns and guide treatment adjustments.
• Pregnancy: Some women experience improvement in OCD during pregnancy (possibly due to high estrogen), while others worsen. ADHD stimulants are generally discontinued during pregnancy due to limited safety data. SSRIs (particularly sertraline) have the most safety data in pregnancy, but the decision to continue, switch, or discontinue medication must weigh individual risks and benefits.
• Postpartum: Both ADHD and OCD can worsen significantly postpartum. Sleep deprivation compounds ADHD symptoms. Postpartum OCD (intrusive thoughts about infant harm) affects 2–5% of new mothers.
• Perimenopause: ADHD symptoms often intensify during perimenopause as estrogen levels decline. Some women are first diagnosed with ADHD during this transition. OCD can also flare during perimenopause.

Children and adolescents with ADHD and/or OCD are entitled to educational accommodations under federal law:

Section 504 plan: Provides accommodations within the general education setting. Requires a documented disability that substantially limits a major life activity (learning). Common 504 accommodations:

• Extended time on tests and assignments
• Preferential seating (near the teacher, away from distractions)
• Permission to take breaks
• Modified homework load
• Use of fidget tools or standing desks
• Access to a quiet testing space

IEP (Individualized Education Program): Provides specialized instruction under the IDEA (Individuals with Disabilities Education Act). Requires that the disability adversely affects educational performance. Offers more intensive services than a 504 plan, including specialized instruction, related services, and measurable goals.

OCD-specific accommodations:

• Permission to leave the classroom to manage anxiety
• Modified assignments during OCD flare-ups
• Reduced emphasis on handwriting perfection for students with symmetry/“just right” OCD
• Communication plan between parents, therapist, and school

Workplace accommodations (ADA): Adults with ADHD or OCD are protected under the Americans with Disabilities Act. Reasonable accommodations may include flexible scheduling, noise-reducing workspace, written (rather than verbal) instructions, permission for breaks, and modified deadlines.

• My child was just diagnosed — should we start with behavioral therapy, medication, or both?
• At what age is medication appropriate for my child’s condition?
• How will medication affect my child’s growth and development?
• What school accommodations should we request, and how do we initiate the process?
• My teenager doesn’t want to take medication — what are our options?
• I’m an adult and think I might have ADHD — where do I start?
• I’m planning a pregnancy — what should I know about my ADHD/OCD medications?
• My OCD symptoms are worse before my period — is there a hormonal connection?
• My child has ADHD and tics — does that change the medication approach?
• How do we plan for the transition from pediatric to adult care?

Beyond medication and therapy, certain everyday habits genuinely move the needle for both ADHD and OCD — not as replacements, but as real additions. The most powerful and most overlooked is sleep: poor sleep worsens attention, impulse control, anxiety, and obsessions, and both conditions (and their medications) can disrupt it, so protecting a regular sleep schedule is one of the highest-yield things you can do. Exercise is close behind — regular physical activity measurably improves focus and mood and reduces anxiety — and it doesn't require an athletic routine to help.

For ADHD specifically, the goal is to build external structure that compensates for the internal executive-function gap rather than relying on willpower: capture tasks in one trusted place (a single list or app), break big tasks into small next-steps, use timers and “body doubling” (working alongside someone), reduce distractions in your environment, and put routines on autopilot so they don't require decisions. These aren't signs of weakness; they are exactly the supports an ADHD brain is helped by, and they work better than “just trying harder.”

For OCD specifically, the daily principle is to keep applying the logic of ERP — resisting compulsions and not seeking reassurance — in everyday moments, and to be alert to stress, sleep loss, and (for some) alcohol or cannabis, which can worsen symptoms. For both conditions, watch the role of caffeine and substances, and treat relapse-prevention as ongoing: know your personal early-warning signs and act on them. None of these replace professional care, but combined with it, they meaningfully raise the ceiling on how well you function and feel.

ADHD and OCD frequently show up most painfully at work and school, and a few principles help you protect both your performance and your wellbeing. The first is that accommodations exist and are often modest. For ADHD, things like extended time on tests, a quieter workspace, written instructions, deadline flexibility, or breaking large projects into checkpoints can level the playing field; for OCD, accommodations might include privacy to manage symptoms, flexibility around triggers, or time for appointments. In the US and many countries, both conditions can qualify for formal accommodations (a 504 plan or IEP in school, ADA accommodations at work) with documentation from your clinician.

The second principle is to build systems rather than rely on willpower — externalize your memory and planning (one calendar, one task list), reduce friction for the things you need to do, and use structure to compensate for the executive-function gap (for ADHD) or to avoid feeding rituals (for OCD). Many people find that the right environment and tools matter as much as medication for day-to-day functioning.

On disclosure: you are generally not required to reveal a diagnosis to an employer, and you can request accommodations through HR or a disability office without sharing clinical details. The decision is personal. What matters most is not silently struggling until you burn out — getting the right treatment, using available supports, and shaping your environment are what let people with ADHD and OCD not just cope but genuinely thrive in demanding roles.

Even with good treatment, both ADHD and OCD have ups and downs — and knowing how to handle a flare keeps a bad stretch from becoming a crisis. The first step is to expect them: stress, poor sleep, illness, big life changes, and (for women) hormonal shifts can all temporarily worsen symptoms, and a flare is not a sign that treatment has failed or that you are back to square one. Recognizing your own early-warning signs — for ADHD, things slipping through the cracks again; for OCD, rituals or avoidance creeping back — lets you act early.

For OCD specifically, the most important response to a flare is to return to the ERP basics rather than to the compulsions: re-engage exposures, resist the urge to seek reassurance, and (for many) reconnect with your therapist for a few booster sessions, which is normal and effective. Resist the temptation to handle rising anxiety by giving in to rituals “just this once,” which is how relapse builds. For ADHD, a flare often means rebuilding structure that has quietly eroded — restarting the systems, tightening routines, and checking whether medication timing still fits your life.

For both, a flare is a cue to look at the basics — sleep, stress, substances, medication adherence — and to reach out rather than withdraw. Most setbacks respond quickly to a tune-up, and having a written plan for “what I'll do when symptoms creep back,” made when you are well, turns a frightening relapse into a manageable, expected part of a long-term condition.

Sleep and both ADHD and OCD exist in a bidirectional relationship: each condition disrupts sleep, and poor sleep worsens symptoms of each condition.

ADHD and sleep: Up to 75% of people with ADHD report sleep problems. The most common are delayed sleep-phase syndrome (difficulty falling asleep and waking), restless sleep, and stimulant-related insomnia. Sleep deprivation worsens attention, emotional regulation, and impulsivity.

OCD and sleep: Intrusive thoughts often intensify at bedtime when external distractions decrease. Bedtime rituals can extend nighttime routines by hours.

Sleep hygiene practices:

• Consistent sleep and wake times — even on weekends
• Dark, cool, quiet bedroom
• No screens for at least 30–60 minutes before bed
• Regular exercise (but not within 2–3 hours of bedtime)
• Avoid caffeine after noon (especially important with stimulant medication)
• Melatonin (0.5–3 mg) 30–60 minutes before bed can help, particularly with stimulant-related sleep difficulties
• For OCD: set a firm “lights out” time and practice accepting that rituals do not need to be completed

Regular physical activity is one of the most robust non-pharmacological interventions for both conditions:

For ADHD: A meta-analysis of exercise interventions found a moderate effect size (d = 0.5) for attention and executive function improvement. Aerobic exercise increases dopamine and norepinephrine in the prefrontal cortex — the same neurotransmitters targeted by ADHD medication. Even a single 20–30 minute session of moderate-intensity exercise can improve focus for several hours afterward.

For OCD: Evidence is moderate but growing. Aerobic exercise reduces anxiety and may enhance ERP outcomes. Exercise should not be used as a compulsion (e.g., exercising to “undo” an intrusive thought), and this distinction should be discussed with the therapist.

Practical recommendations:

• Aim for 30–45 minutes of moderate aerobic exercise on most days
• Choose activities you enjoy — adherence matters more than the specific exercise
• Morning exercise can help with focus and mood for the rest of the day
• Team sports and martial arts offer structure and social engagement alongside physical activity
• For children: active recess and physical education should be protected, not withheld as punishment

There is no proven “ADHD diet” or “OCD diet,” but good nutrition supports brain function and overall well-being:

• Balanced, regular meals: Blood sugar stability affects attention and mood. Skipping meals — common when stimulants suppress appetite — worsens afternoon symptoms.
• Omega-3 fatty acids: Meta-analyses show a small but significant benefit for ADHD symptoms (effect size d = 0.2–0.3). Found in fatty fish, walnuts, and flaxseed, or available as supplements (EPA/DHA). Not a substitute for medication, but a reasonable adjunct.
• Protein with medication: Taking stimulant medication with protein-containing food can improve absorption and extend effect duration.
• Caffeine: Many adults with undiagnosed ADHD self-medicate with caffeine. Once on medication, caffeine intake may need adjustment to avoid overstimulation and sleep disruption.
• Elimination diets: Some studies suggest a small subset of children with ADHD may respond to elimination of artificial food colorings. Evidence is limited and individual. Major medical organizations do not recommend elimination diets as standard treatment.

Mindfulness can be a helpful adjunct for both ADHD and OCD, but with an important caveat for OCD:

For ADHD: Mindfulness meditation helps train sustained attention and emotional regulation. Research shows modest improvements in attention and executive function with regular practice. Apps like Headspace and Calm offer guided sessions that can be helpful for beginners.

For OCD — proceed with care: Mindfulness must be adapted for OCD. The goal is acceptance of uncertainty and willingness to sit with discomfort — aligned with ERP principles. However, mindfulness can become a compulsion if used to “neutralize” intrusive thoughts or achieve a feeling of mental purity. A therapist experienced in both mindfulness and OCD should guide this integration.

Acceptance and Commitment Therapy (ACT): An evidence-based approach that combines mindfulness, acceptance, and values-based action. Increasingly used as an adjunct to ERP for OCD and as a standalone or complementary treatment for ADHD.

Stress is a reliable trigger for both ADHD symptom worsening and OCD flare-ups. Building a stress management toolkit is essential:

• Identify stress signals early: Increased forgetfulness (ADHD) or increased ritual frequency (OCD) are often early signs of stress overload.
• Set realistic expectations: Overcommitment is common in ADHD (impulsive yes-saying) and OCD (perfectionism). Learning to say no is a therapeutic skill.
• Build routines: Predictable daily structure reduces the decision load and provides a framework that both conditions benefit from.
• Social connection: Isolation worsens both conditions. Even brief, regular social contact is protective.
• Nature exposure: Research shows that time in green spaces can reduce ADHD symptoms in children. Even 20 minutes outdoors can improve attention.

Both ADHD and OCD carry a heavy emotional burden that goes beyond the primary symptoms:

• Shame: Years of “You’re smart enough, you just need to try harder” leave deep marks on self-worth. OCD shame is often about the content of intrusive thoughts. Naming the shame and understanding its origins is the first step toward healing.
• Perfectionism: Paradoxically, ADHD can drive perfectionism — as a compensatory strategy against the fear of making mistakes. OCD can drive perfectionism through fear of imperfection causing harm. Both forms are exhausting and counterproductive.
• Self-compassion: Research shows that self-compassion interventions improve outcomes for both conditions. Treating yourself with the kindness you would offer a friend in the same situation is not weakness — it is a skill backed by evidence.
• Therapy for the emotional layer: Even after symptoms are controlled, many people benefit from therapy to address the accumulated emotional damage — grief for lost time, relationship repair, and rebuilding self-concept.

Caring for a child or living with a partner who has ADHD and/or OCD is demanding. Caregiver burnout is real and must be proactively managed:

• You cannot pour from an empty cup. Your own mental health is not optional — it is infrastructure. Regular exercise, sleep, and social contact are non-negotiable.
• Join a support group. CHADD, IOCDF, and NAMI all offer caregiver-specific support groups (in-person and online). Hearing from others in similar situations reduces isolation and provides practical strategies.
• Family therapy: A therapist who understands ADHD and/or OCD can help the entire family system adjust. Family therapy addresses communication patterns, accommodation reduction, and shared problem-solving.
• Respite: Plan regular breaks. Enlist family, friends, or respite care services. Taking time for yourself is not selfish — it is necessary for sustained caregiving.
• Educate yourself: Understanding the neurobiology helps replace frustration with empathy. When you know that your child’s forgetfulness is a brain wiring issue (not defiance) or that your partner’s rituals are driven by genuine anxiety (not stubbornness), your emotional response shifts.

Technology can be a powerful ally when used intentionally:

For ADHD:

• Task management: Todoist, TickTick, and Notion offer external structure for task tracking
• Time management: Tiimo (visual schedule), Forest (focus timer), and Time Timer (visual countdown)
• Focus and distraction blocking: Freedom, Cold Turkey, and Focus@Will
• Body doubling: Focusmate pairs you with a virtual accountability partner
• Note-taking: Otter.ai for meeting transcription, Notion for knowledge management

For OCD:

• NOCD: Connects users with ERP-trained therapists via telehealth and provides between-session tools
• nOCD (self-help): Free app for tracking OCD triggers, severity, and exposure practice
• Mood tracking: Daylio, MoodFit, or Bearable for tracking symptom patterns over time

Caution: Technology can also be a distraction (ADHD) or a vehicle for reassurance-seeking (OCD). Set boundaries around phone use and be mindful of how you use apps.

• What lifestyle changes have the best evidence for improving my symptoms?
• Can you recommend a specific exercise plan that fits my condition?
• I’m having significant sleep difficulties — should we adjust my medication timing?
• Is melatonin safe for me (or my child) to use for sleep?
• Should I try omega-3 supplements?
• I’m interested in mindfulness — are there adaptations I should know about for OCD?
• My partner/child is struggling and so am I — can you recommend family therapy resources?
• Are there support groups you recommend for caregivers?

ADHD and OCD attract a lot of confidently marketed treatments that don't hold up — and knowing how to evaluate them protects your time, money, and hope. For ADHD, two of the most heavily promoted are neurofeedback (brain-training using EEG) and elimination diets. When tested rigorously against a convincing sham, neurofeedback has not shown a real effect on ADHD symptoms — its apparent benefits come from expectation and the general attention of treatment — and broad elimination diets help only a small minority sensitive to specific food dyes, not ADHD generally. Supplement and “detox” regimens marketed as ADHD cures are likewise unsupported.

For OCD, the important caution is that not all therapy is equal: traditional “talk therapy” that digs into the meaning of the obsessions can actually make OCD worse (the analysis becomes another compulsion), and anti-anxiety sedatives don't treat the underlying disorder. The evidence-based treatment is specifically ERP, so “we'll just talk about it” is a sign to ask whether the therapist is ERP-trained.

The simple, powerful question to bring to anything you're considering — a supplement, a device, a special diet, a clinic's program — is: “Has this been tested in good-quality studies for this condition, and what did they show?” Treatments proven in proper trials (stimulants and behavioral strategies for ADHD; ERP and SSRIs for OCD) have earned your investment; those resting on testimonials or marketing have not. Being open to new options is healthy — demanding evidence before spending on them is what keeps that openness from being exploited.

• Pemoline (Cylert) WITHDRAWN
  Pemoline was a stimulant medication approved for ADHD in 1975. The FDA added a black-box warning in 1999 after reports of liver failure, including cases requiring liver transplantation and at least 13 deaths. It was withdrawn from the US market in 2005. Pemoline should not be used for ADHD under any circumstances. Safe, effective stimulant alternatives (methylphenidate, amphetamine salts) are widely available.
• EEG biofeedback (neurofeedback) as a standalone ADHD treatment FAILED
  Multiple well-controlled trials, including sham-controlled studies, have failed to demonstrate that neurofeedback is superior to placebo for core ADHD symptoms when blinded outcome measures are used. A 2021 meta-analysis in the Journal of Child Psychology and Psychiatry found no significant effect when only probably blinded assessments were analyzed. The European ADHD Guidelines Group (EAGG) does not recommend it. It remains expensive, time-consuming, and unproven as a standalone treatment.
• Elimination diets and the Feingold Diet for ADHD DE-ADOPTED
  The Feingold Diet (eliminating artificial food colors, flavors, and salicylates) was widely promoted in the 1970s and 1980s. Controlled trials failed to show meaningful benefit for the majority of children with ADHD. While a small subset of children may be sensitive to certain artificial food colors, broad elimination diets are not recommended as ADHD treatment by any major medical guideline (AAP, NICE, CADDRA). They can cause nutritional deficiencies and family stress without addressing core symptoms.
• Megavitamin and orthomolecular therapy for ADHD FAILED
  High-dose vitamin regimens (especially B vitamins and vitamin C) were promoted in the 1970s and 1980s as ADHD treatments. Controlled trials showed no benefit over placebo for ADHD symptoms, and high-dose vitamin supplementation carries risks of toxicity. The AAP and NICE do not recommend megavitamin therapy for ADHD.
• Desipramine for pediatric ADHD DE-ADOPTED
  This tricyclic antidepressant was once used off-label for ADHD in children but was linked to sudden cardiac death in at least four pediatric cases. Its use in children was abandoned due to cardiac risks including QTc prolongation. Safer non-stimulant options (atomoxetine, guanfacine, clonidine) are now available.

• Psychoanalytic therapy as primary OCD treatment DE-ADOPTED
  For decades, psychoanalytic and psychodynamic therapy was the primary approach to OCD. Multiple controlled trials demonstrated that traditional psychoanalysis does not meaningfully reduce obsessions or compulsions. OCD is now understood as a neurobiological condition best treated with CBT/ERP and/or SRIs. No major guideline (APA, NICE, AACAP) recommends psychoanalytic therapy for OCD. Prolonged exploration of the “meaning” of obsessions can actually worsen symptoms by functioning as a mental compulsion.
• Benzodiazepines as primary OCD treatment DE-ADOPTED
  Benzodiazepines (such as clonazepam and lorazepam) were once used for OCD due to their anti-anxiety effects. Controlled evidence shows they do not reduce obsessions or compulsions. Worse, by reducing anxiety, they can interfere with ERP (which requires controlled anxiety exposure to work). They also carry risks of dependence and cognitive impairment. NICE and APA guidelines recommend against benzodiazepines for OCD.
• Ondansetron for OCD FAILED
  This 5-HT3 receptor antagonist (an anti-nausea medication) was investigated as an augmentation agent for treatment-resistant OCD based on serotonergic theory. A randomized controlled trial published in the Journal of Clinical Psychiatry (2014) found no significant benefit over placebo as an SSRI augmentation strategy for OCD.

Finding the right help for ADHD or OCD can be its own challenge, so a few pointers save time and frustration. For OCD, the single most important search is for a therapist specifically trained in ERP — not just any counselor — and the International OCD Foundation's directory (iocdf.org) lets you filter for exactly that, including telehealth. For ADHD, a clinician comfortable diagnosing and treating it (some primary-care doctors, many psychiatrists and psychiatric nurse practitioners, and ADHD specialty clinics) is the goal; organizations like CHADD and ADDA offer directories and support.

Access barriers are real, and there are workarounds. Telehealth has dramatically widened access to both ERP therapists and ADHD prescribers, which is especially valuable in areas with few specialists — though note that controlled ADHD stimulants sometimes have extra rules for telehealth prescribing. If cost is a barrier: community mental health centers and university training clinics offer lower-cost care, employee assistance programs (EAPs) provide a few free confidential sessions, and many medications have generic or assistance-program options. Internet-delivered CBT programs are an emerging, lower-cost option for milder cases or while waiting for a therapist.

Two practical tips. First, keep a simple personal record of what you have tried (medications, doses, therapists, what helped) — it dramatically speeds up care with any new provider. Second, don't let a long waitlist stop you from starting: a primary-care clinician can often begin ADHD treatment or an SSRI for OCD while you wait for a specialist, and support organizations and crisis lines (988 for any mental-health crisis) can bridge the gap. You deserve effective, evidence-based care, and persistence in finding it pays off.

If someone you love has ADHD or OCD, your support matters enormously — and the most helpful approach is often different from your instinct. For ADHD, the key reframe is that the forgetfulness, lateness, disorganization, or unfinished tasks are symptoms of a brain-based difference, not laziness or not caring. Nagging and criticism rarely help and erode the relationship; what helps is collaborating on external systems (shared calendars, reminders, breaking tasks down), focusing on strengths, and recognizing genuine effort even when results lag. With children, consistent routines, clear expectations, and behavioral approaches (often via parent training) work better than punishment.

For OCD, the most important and counterintuitive lesson is about accommodation. Families naturally try to help by providing reassurance, helping with rituals, or arranging life around the person's fears — but this feeds the OCD and makes it stronger. With guidance from the person's ERP therapist, gradually reducing accommodation (lovingly, as a team, not abruptly) is one of the most powerful things a family can do. Treat the intrusive thoughts as symptoms, not as reflections of the person's character.

Across both conditions, take care of yourself too: supporting someone with a mental-health condition is draining, and your steadiness depends on your own support and limits. Learn about the condition (organizations like CHADD, the IOCDF, and NAMI offer family programs), involve the person in decisions rather than taking over, and celebrate progress, which is often gradual. Being informed, patient, and willing to learn the counterintuitive parts is exactly the support that helps most.

• CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder): chadd.org — The leading ADHD organization. Offers educational resources, support groups, a National Resource Center on ADHD (funded by the CDC), a professional directory, and a helpline: 1-866-200-8098.
• IOCDF (International OCD Foundation): iocdf.org — The leading OCD organization. Offers a therapist directory (the best way to find ERP-trained providers), educational resources, an annual conference, support groups, and advocacy. Provides specific resources for subtypes including hoarding, BDD, and tic disorders.
• ADDA (Attention Deficit Disorder Association): add.org — Focused specifically on adult ADHD. Offers virtual support groups, webinars, and a professional directory.
• NAMI (National Alliance on Mental Illness): nami.org — Offers education programs (Family-to-Family, Peer-to-Peer), support groups, advocacy, and a helpline: 1-800-950-NAMI (6264).
• AADPA (American Academy of Developmental Pediatrics and ADHD): Provides resources specifically for pediatric ADHD care and advocacy for evidence-based treatment.
• Anxiety & Depression Association of America (ADAA): adaa.org — Offers a therapist finder, webinars, and educational materials for anxiety disorders including OCD.

• Huntsman Mental Health Institute (HMHI): Formerly the University of Utah Neuropsychiatric Institute (UNI). Located at 501 Chipeta Way, Salt Lake City. Provides comprehensive psychiatric services including ADHD evaluation and OCD treatment. Emergency psychiatric services available 24/7: 801-583-2500.
• Utah OCD and Anxiety Treatment Center: Specializes in OCD and anxiety disorders. Offers intensive outpatient programs (IOP) and individual ERP therapy. Multiple Utah locations.
• University of Utah ADHD Clinic: Part of the Department of Psychiatry. Provides comprehensive ADHD evaluation for children, adolescents, and adults. Neuropsychological testing available.
• CHADD Utah Chapter: Local chapter offering support groups, educational events, and community connections for families affected by ADHD. Check chadd.org for meeting schedules.
• OCD Utah: A state affiliate of the IOCDF that provides local education, support groups, and annual awareness events.
• Utah Crisis Line: Call 988 (statewide). The University of Utah operates the local 988 crisis call center with trained counselors available 24/7.
• SafeUT: A crisis text and tip line for youth. Available via app or by calling 833-372-3388.

• 988 Suicide & Crisis Lifeline: Call or text 988. Available 24/7. Free and confidential. Serves anyone in emotional distress, not just those experiencing suicidal thoughts.
• Crisis Text Line: Text HOME to 741741 to connect with a trained crisis counselor via text message. Available 24/7.
• SAMHSA National Helpline: 1-800-662-4357. Free, confidential, 24/7 referral and information service for substance abuse and mental health disorders.
• Trevor Project: 1-866-488-7386 or text START to 678-678. Crisis intervention for LGBTQ+ youth.
• Veterans Crisis Line: Call 988, then press 1. Or text 838255.

Note: Suicidal ideation can co-occur with both ADHD (particularly due to impulsivity and emotional dysregulation) and OCD (particularly harm-themed OCD). If you are experiencing suicidal thoughts, please reach out to one of these services immediately.

For ADHD:

• Driven to Distraction by Edward Hallowell, MD, and John Ratey, MD — A foundational book for understanding ADHD in adults and children
• Taking Charge of ADHD by Russell Barkley, PhD — The definitive parent guide, grounded in research
• A Radical Guide for Women with ADHD by Sari Solden, MS, and Michelle Frank, PsyD — Addresses the unique experience of women with ADHD
• Smart but Scattered by Peg Dawson, EdD, and Richard Guare, PhD — Practical executive function strategies for children and teens

For OCD:

• Brain Lock by Jeffrey Schwartz, MD — A classic self-help guide using cognitive techniques for OCD
• Freedom from Obsessive-Compulsive Disorder by Jonathan Grayson, PhD — A comprehensive ERP-based self-help program
• Everyday Mindfulness for OCD by Jon Hershfield, MFT, and Shala Nicely, LPC — Integrates mindfulness with ERP principles
• What to Do When Your Brain Gets Stuck by Dawn Huebner, PhD — A workbook for children with OCD (ages 6–12)

For families:

• Loving Someone with OCD by Karen Landsman, PsyD, et al. — A guide for partners and family members
• The Couple’s Guide to Thriving with ADHD by Melissa Orlov and Nancie Kohlenberger, LMFT

Support groups provide connection, shared experience, and practical strategies. They are not a substitute for professional treatment but are a powerful complement:

In-person:

• CHADD local chapters offer monthly support groups for adults with ADHD and parents of children with ADHD
• IOCDF-affiliated support groups for OCD meet regularly in many cities
• NAMI support groups are available in nearly every community

Online:

• ADDA virtual support groups for adult ADHD (weekly, small-group format)
• IOCDF online support groups (moderated, condition-specific)
• Reddit communities: r/ADHD and r/OCD are large and active, though they are peer-moderated and not a substitute for professional advice
• CHADD helpline provides one-on-one support: 1-866-200-8098

Cost and insurance barriers are among the most common obstacles to treatment. Strategies for managing these barriers:

• Mental health parity: The Mental Health Parity and Addiction Equity Act requires most insurance plans to cover mental health services at the same level as medical services. If your insurer denies coverage, request a written explanation and file an appeal.
• Prior authorization: Many plans require prior authorization for psychiatric medications or neuropsychological testing. Your provider’s office can initiate this process.
• Patient assistance programs: Most pharmaceutical manufacturers offer patient assistance programs for medications including stimulants and SSRIs. Ask your prescriber or pharmacist about these.
• Generic medications: Generic formulations of most ADHD and OCD medications are available at significantly lower cost. Discuss generic options with your prescriber.
• Sliding scale therapy: Many therapists offer sliding-scale fees. Psychology Today’s therapist finder (psychologytoday.com) allows filtering by insurance and payment options.
• Community mental health centers: Federally qualified health centers provide mental health services on a sliding fee scale based on income.
• University training clinics: Clinical psychology and psychiatry training programs often offer services at reduced cost, supervised by experienced faculty.

• Can you recommend specific therapists or clinics in my area that specialize in ADHD/OCD?
• Is there a support group you recommend for me or my family?
• What resources do you have for navigating insurance coverage for my treatment?
• Are there patient assistance programs for my medications?
• If I need intensive treatment (residential or IOP), how do I access it?
• Can you help me write a letter for school/workplace accommodations?
• What should I do if I’m in crisis outside of office hours?
• Are there clinical trials I might be eligible for?

• Huntsman Mental Health Institute (HMHI) — University of Utah. Comprehensive ADHD evaluation and OCD treatment (ERP). 501 Chipeta Way, Salt Lake City. 801-583-2500.
• University of Utah ADHD Clinic — Department of Psychiatry. Neuropsychological testing for children, adolescents, and adults.
• Utah OCD and Anxiety Treatment Center — Specializes in OCD/anxiety. Intensive outpatient (IOP) and individual ERP. Multiple Utah locations.

• McLean Hospital OCD Institute — Belmont, MA. Residential and partial hospitalization for OCD. One of the oldest and largest OCD specialty programs. 617-855-3279.
• Rogers Behavioral Health — Oconomowoc, WI (+ national locations). Residential and intensive programs for OCD, anxiety, and ADHD. 800-767-4411.
• NOCD — National telehealth ERP provider. Specializes in OCD. Accepted by many insurance plans. nocd.com.
• Massachusetts General Hospital ADHD Clinical & Research Program — Boston. 617-726-0226.
• NYU Langone ADHD Program — New York. Comprehensive adult and pediatric evaluation. 212-263-3580.
• The IOCDF therapist directory (iocdf.org/find-help) is the best tool for finding ERP-trained providers near you.

• VA Salt Lake City Health Care System — mental health services. 801-582-1565.
• VA provides ADHD evaluation and treatment (including stimulants) and OCD treatment (ERP programs at select VA centers).
• Veterans Crisis Line: Call 988, press 1. Text 838255.

• CADDRA (Canadian ADHD Resource Alliance) — caddra.ca. Canadian guideline publisher, provider directory, and patient resources.
• Anxiety Canada — anxietycanada.com. Free CBT-based self-help programs (MindShift app) and OCD resources.
• Centre for Addiction and Mental Health (CAMH) — Toronto. Canada’s largest mental health hospital. ADHD and OCD programs.

• Maudsley Hospital / South London and Maudsley NHS Trust — London, UK. National OCD Service and ADHD Adult Service.
• ADHD Europe — adhdeurope.eu. Pan-European advocacy and information network.
• IACAPAP (International Association for Child and Adolescent Psychiatry) — publishes free international textbook chapters on ADHD and OCD.

• ERP (Exposure and Response Prevention) — the gold-standard behavioral therapy for OCD. Involves gradual, structured exposure to anxiety-provoking triggers while refraining from compulsive responses.
• Y-BOCS (Yale-Brown Obsessive Compulsive Scale) — the standard clinician-administered measure of OCD severity. Score ranges: 0–7 subclinical, 8–15 mild, 16–23 moderate, 24–31 severe, 32–40 extreme.
• Executive function — a set of cognitive processes including working memory, flexible thinking, and self-control. Impaired in ADHD; affects planning, organization, time management, and impulse regulation.
• Ego-dystonic vs. ego-syntonic — OCD thoughts are ego-dystonic (experienced as unwanted, distressing, and inconsistent with the person’s values). This distinguishes OCD from conditions where the thoughts feel natural or desired.
• CSTC circuit (Cortico-Striato-Thalamo-Cortical) — the brain circuit implicated in OCD. Dysfunction in this loop is the leading neurobiological model for obsessive-compulsive symptoms.
• Effect size — a statistical measure of how large a treatment’s impact is. In ADHD, stimulants have large effect sizes (~0.8–1.0); non-stimulants have moderate effect sizes (~0.4–0.6). Larger = more impact.
• SRI/SSRI — Serotonin Reuptake Inhibitor / Selective Serotonin Reuptake Inhibitor. First-line medications for OCD (fluoxetine, fluvoxamine, sertraline, paroxetine, escitalopram). OCD typically requires higher doses than depression.
• Stimulant — medications that increase dopamine and norepinephrine (methylphenidate, amphetamine). First-line for ADHD. Schedule II controlled substances.
• Comorbidity — the co-occurrence of two or more conditions. ADHD and OCD commonly co-occur with anxiety, depression, tic disorders, and learning disabilities.